An immunotherapy cocktail from Roche helped slow a type of breast cancer where new treatments have proven elusive, data released on Saturday showed, offering positive news for the Swiss drugmaker as it chases medicines produced by its rivals.... REUTERS 4 weeks
A new trial confirms that a combination of immunotherapy and chemotherapy boosts survival rates for people with triple-negative breast cancer.
more... MNT 3 weeks
New research has shown that by using a combination of immunotherapy and chemotherapy the body's own immune system can be tuned to attack triple-negative breast cancer, extending survival.
more... SCIENCE DAILY 3 weeks
Immunotherapy improves survival in some patients with metastatic triple negative breast cancer, according to late-breaking results from the IMpassion130 trial reported at the ESMO...
more... NEWS MEDICAL 4 weeks
Roche's Tecentriq plus chemotherapy boosted lung cancer patients' survival by nearly five months, study...
more... REUTERS 4 weeks
Screening Food and Drug Administration approved compounds for their ability to stop cancer growth in the lab led to the finding that...
An immunotherapy cocktail from Roche helped slow an aggressive type of breast cancer where new treatments...
more... REUTERS 4 weeks
There is new hope for people with an aggressive type of breast cancer, as an immunotherapy trial shows for the first time that lives can be...
more... NEWS MEDICAL 4 weeks
Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced breast cancer with the alpha-specific phosphatidylinositol-3-kinase (PI3K) inhibitor alpelisib significantly improves progression-free survival,...
more... NEWS MEDICAL 4 weeks
A new study has shown that a combination of drugs palbociclib, along with hormone therapy can significantly increase the survival among women with advanced breast cancer.
more... NEWS MEDICAL 4 weeks
Treatment with the cyclin dependent kinase 4/6 inhibitor palbociclib achieves a clinically meaningful improvement in overall survival in...
more... NEWS MEDICAL 3 weeks
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical trial.
more... SCIENCE DAILY 3 weeks
New research looking at the data of tens of thousands of women finds that screening for breast cancer has an important impact on survival.
more... MNT 4 days
The drug palbociclib, used in combination with standard treatment, improved survival for women with hormone receptor-positive metastatic breast cancer, according to a large phase III clinical...
more... NEWS MEDICAL 3 weeks
Pfizer Inc. today announced detailed overall survival data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to...
more... NEWS MEDICAL 4 weeks
Combining a targeted drug with hormone therapy substantially extends survival for women with advanced breast cancer, a major clinical trial has found.
more... NEWS MEDICAL 4 weeks
Final results of a clinical trial show continued evidence that women who get injections of the hormone drug goserelin along with standard breast cancer chemotherapy are more likely to become...
more... SCIENCE DAILY 2 weeks
Houston Methodist scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer.
more... NEWS MEDICAL 3 weeks
Final results of SWOG Cancer Research Network's groundbreaking international Prevention of Early Menopause Study clinical trial are in, and they show continued evidence that women who...
Networking more... NEWS MEDICAL 3 weeks
Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the aromatase inhibitor letrozole significantly increases disease-free survival compared...
more... NEWS MEDICAL 4 weeks
Scientists have developed a nanodevice to deliver immunotherapy without side effects to treat triple-negative breast cancer. Inserted straight into a tumor, this device makes it possible to deliver a one-time, sustained-release dose...
more... SCIENCE DAILY 3 weeks
Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy...
more... NEWS MEDICAL 4 weeks
Nearly one in six premenopausal women being treated for early stage breast cancer do not adhere adequately to tamoxifen therapy...
more... NEWS MEDICAL 4 weeks
Kata Carter was diagnosed with breast cancer when her youngest daughter was three-months-old.
Cancer more... ABC NEWS 3 days
A pay it forward chain that began with two nurses in an Indianapolis has allowed a mother of three battling breast cancer to feed her 10-month-old daughter breast...
Cancer more... ABC NEWS 2 days
Women with HER2-positive early breast cancer with small tumours have similar disease-free survival and lower risk of cardiac...
more... NEWS MEDICAL 4 weeks
Roche's entrectinib cancer pill was shown to shrink tumors in 57 percent of patients within a group that...
more... REUTERS 4 weeks
Researchers have identified a protein that determines the identity and invasive properties of breast cancer cells. The finding could lead to the development of new therapeutic and diagnostic strategies to...
more... SCIENCE DAILY 2 weeks
Scientists found that the combined effect of common genetic variations can dramatically increase risk of breast cancer for female pediatric...
more... SCIENCE DAILY 3 weeks
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes...
Here's what you need to know about breast cancer disparities, and why do they still exist?
more... ABC NEWS 4 weeks
Is it a bird? Is it a plane?
ESA
Neutron pinhole magnifies discoveries at ORNL
PHYS.ORG
Game-Changers in Western Blotting and Protein Analysis
NEWS MEDICAL
Medical News Today: What are the best stretches for tight hamstrings?
MNT
Commercial EO innovation challenges snail-pace government timescales
SPACE NEWS
Designer emulsions
PHYS.ORG
Big jobs: Safety, planning key to increasing production performance at Spallation Neutron Source
PHYS.ORG
Concrete printing in 3-D will put an end to boring buildings
PHYS.ORG
Harnessing artificial intelligence for sustainability goals
ESA
Palm oil boycott could actually increase deforestation – sustainable products are the solution
PHYS.ORG
Direct observations of a planet orbiting a star 63 light-years away
PHYS.ORG
A Decade of Commercial Space Travel — What's Next?
SPACE.COM
Pioneering sociologist foresaw our current chaos 100 years ago
PHYS.ORG
Volcanic eruptions once caused mass extinctions in the oceans – could climate change do the same?
PHYS.ORG
Scientists uncover crucial biological circuits that regulate lipids and their role in overall health
PHYS.ORG
Trending
 
Fresh
what is What is ɸ? ESA 38 minutes more...